Precision Oncology Market Size, Trends, Analysis, and Outlook By Product (Diagnostics, Therapeutics), By Cancer (Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, Others), By End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies), by Region, Country, Segment, and Companies, 2024-2030
The global Precision Oncology market size is poised to register 10.81% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Precision Oncology market across By Product (Diagnostics, Therapeutics), By Cancer (Breast Cancer, Colorectal Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, Others), By End-user (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Healthcare Data Companies).
The Precision Oncology Market is experiencing growth propelled by increasing prevalence of cancer, expanding applications of genomic medicine, and advancements in molecular diagnostics and targeted therapies. Precision oncology involves the use of genomic profiling, molecular biomarkers, and personalized treatment strategies to optimize cancer care and improve patient outcomes. Key trends shaping its future include the development of comprehensive genomic profiling assays for tumor characterization and treatment selection, integration of artificial intelligence and machine learning algorithms for data interpretation and clinical decision support, and expansion of targeted therapy options and combination treatment approaches. Additionally, increasing adoption of next-generation sequencing technologies in oncology practice, expansion of precision medicine initiatives and oncology research collaborations, and regulatory approvals for companion diagnostics and targeted cancer therapies contribute to market growth.
Precision Oncology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Precision Oncology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Precision Oncology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Precision Oncology industry.
Key market trends defining the global Precision Oncology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Precision Oncology Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Precision Oncology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Precision Oncology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Precision Oncology industry
Leading Precision Oncology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Precision Oncology companies.
Precision Oncology Market Study- Strategic Analysis Review
The Precision Oncology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Precision Oncology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Precision Oncology Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Precision Oncology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Precision Oncology market segments. Similarly, Strong end-user demand is encouraging Canadian Precision Oncology companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Precision Oncology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Precision Oncology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Precision Oncology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Precision Oncology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Precision Oncology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Precision Oncology in Asia Pacific. In particular, China, India, and South East Asian Precision Oncology markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Precision Oncology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Precision Oncology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Precision Oncology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Precision Oncology.
Precision Oncology Market Company Profiles
The global Precision Oncology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Acrivon Therapeutics, Bioserve, Exact Sciences Corp, Illumina Inc, Invitae Corp, Laboratory Corp Of America Holding, Qiagen N.V., Rain Oncology Inc, Relay Therapeutics, Strata Oncology Inc, Thermo Fisher Scientific Inc, Variantyx Inc, Xilis Inc
Recent Precision Oncology Market Developments
The global Precision Oncology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Precision Oncology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies
Geographical Segmentation:
Acrivon Therapeutics
Bioserve
Exact Sciences Corp
Illumina Inc
Invitae Corp
Laboratory Corp Of America Holding
Qiagen N.V.
Rain Oncology Inc
Relay Therapeutics
Strata Oncology Inc
Thermo Fisher Scientific Inc
Variantyx Inc
Xilis Inc
Formats Available: Excel, PDF, and PPT
The Precision Oncology Market is experiencing growth propelled by increasing prevalence of cancer, expanding applications of genomic medicine, and advancements in molecular diagnostics and targeted therapies. Precision oncology involves the use of genomic profiling, molecular biomarkers, and personalized treatment strategies to optimize cancer care and improve patient outcomes. Key trends shaping its future include the development of comprehensive genomic profiling assays for tumor characterization and treatment selection, integration of artificial intelligence and machine learning algorithms for data interpretation and clinical decision support, and expansion of targeted therapy options and combination treatment approaches. Additionally, increasing adoption of next-generation sequencing technologies in oncology practice, expansion of precision medicine initiatives and oncology research collaborations, and regulatory approvals for companion diagnostics and targeted cancer therapies contribute to market growth.
Precision Oncology Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Precision Oncology market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Precision Oncology survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Precision Oncology industry.
Key market trends defining the global Precision Oncology demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Precision Oncology Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Precision Oncology industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Precision Oncology companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Precision Oncology industry
Leading Precision Oncology companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Precision Oncology companies.
Precision Oncology Market Study- Strategic Analysis Review
The Precision Oncology market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Precision Oncology industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Precision Oncology Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Precision Oncology Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Precision Oncology market segments. Similarly, Strong end-user demand is encouraging Canadian Precision Oncology companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Precision Oncology market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Precision Oncology Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Precision Oncology industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Precision Oncology market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Precision Oncology Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Precision Oncology in Asia Pacific. In particular, China, India, and South East Asian Precision Oncology markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Precision Oncology Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Precision Oncology Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Precision Oncology market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Precision Oncology.
Precision Oncology Market Company Profiles
The global Precision Oncology market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are Acrivon Therapeutics, Bioserve, Exact Sciences Corp, Illumina Inc, Invitae Corp, Laboratory Corp Of America Holding, Qiagen N.V., Rain Oncology Inc, Relay Therapeutics, Strata Oncology Inc, Thermo Fisher Scientific Inc, Variantyx Inc, Xilis Inc
Recent Precision Oncology Market Developments
The global Precision Oncology market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Precision Oncology Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
Acrivon Therapeutics
Bioserve
Exact Sciences Corp
Illumina Inc
Invitae Corp
Laboratory Corp Of America Holding
Qiagen N.V.
Rain Oncology Inc
Relay Therapeutics
Strata Oncology Inc
Thermo Fisher Scientific Inc
Variantyx Inc
Xilis Inc
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Precision Oncology Market Overview and Key Findings, 2024
1.2 Precision Oncology Market Size and Growth Outlook, 2021- 2030
1.3 Precision Oncology Market Growth Opportunities to 2030
1.4 Key Precision Oncology Market Trends and Challenges
1.4.1 Precision Oncology Market Drivers and Trends
1.4.2 Precision Oncology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Precision Oncology Companies
2. PRECISION ONCOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 Precision Oncology Market Size Outlook, USD Million, 2021- 2030
2.2 Precision Oncology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PRECISION ONCOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PRECISION ONCOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Precision Oncology Market, 2025
5.2 Asia Pacific Precision Oncology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Precision Oncology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Precision Oncology Market, 2025
5.5 Europe Precision Oncology Market Size Outlook by Type, 2021- 2030
5.6 Europe Precision Oncology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Precision Oncology Market, 2025
5.8 North America Precision Oncology Market Size Outlook by Type, 2021- 2030
5.9 North America Precision Oncology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Precision Oncology Market, 2025
5.11 South America Pacific Precision Oncology Market Size Outlook by Type, 2021- 2030
5.12 South America Precision Oncology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Precision Oncology Market, 2025
5.14 Middle East Africa Precision Oncology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Precision Oncology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Precision Oncology Market Size Outlook and Revenue Growth Forecasts
6.2 US Precision Oncology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Precision Oncology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Precision Oncology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Precision Oncology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Precision Oncology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Precision Oncology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Precision Oncology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Precision Oncology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Precision Oncology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Precision Oncology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Precision Oncology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Precision Oncology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Precision Oncology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Precision Oncology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Precision Oncology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Precision Oncology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Precision Oncology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Precision Oncology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Precision Oncology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Precision Oncology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Precision Oncology Industry Drivers and Opportunities
7. PRECISION ONCOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PRECISION ONCOLOGY COMPANY PROFILES
8.1 Profiles of Leading Precision Oncology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Acrivon Therapeutics
Bioserve
Exact Sciences Corp
Illumina Inc
Invitae Corp
Laboratory Corp Of America Holding
Qiagen N.V.
Rain Oncology Inc
Relay Therapeutics
Strata Oncology Inc
Thermo Fisher Scientific Inc
Variantyx Inc
Xilis Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Precision Oncology Market Overview and Key Findings, 2024
1.2 Precision Oncology Market Size and Growth Outlook, 2021- 2030
1.3 Precision Oncology Market Growth Opportunities to 2030
1.4 Key Precision Oncology Market Trends and Challenges
1.4.1 Precision Oncology Market Drivers and Trends
1.4.2 Precision Oncology Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Precision Oncology Companies
2. PRECISION ONCOLOGY MARKET SIZE OUTLOOK TO 2030
2.1 Precision Oncology Market Size Outlook, USD Million, 2021- 2030
2.2 Precision Oncology Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. PRECISION ONCOLOGY MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. PRECISION ONCOLOGY MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Product
Diagnostics
Therapeutics
By Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Prostate Cancer
Lung Cancer
Others
By End-User
Hospitals & Diagnostic Laboratories
Pharmaceutical & Biotechnology Companies
Healthcare Data Companies
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Precision Oncology Market, 2025
5.2 Asia Pacific Precision Oncology Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Precision Oncology Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Precision Oncology Market, 2025
5.5 Europe Precision Oncology Market Size Outlook by Type, 2021- 2030
5.6 Europe Precision Oncology Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Precision Oncology Market, 2025
5.8 North America Precision Oncology Market Size Outlook by Type, 2021- 2030
5.9 North America Precision Oncology Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Precision Oncology Market, 2025
5.11 South America Pacific Precision Oncology Market Size Outlook by Type, 2021- 2030
5.12 South America Precision Oncology Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Precision Oncology Market, 2025
5.14 Middle East Africa Precision Oncology Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Precision Oncology Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Precision Oncology Market Size Outlook and Revenue Growth Forecasts
6.2 US Precision Oncology Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Precision Oncology Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Precision Oncology Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Precision Oncology Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Precision Oncology Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Precision Oncology Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Precision Oncology Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Precision Oncology Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Precision Oncology Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Precision Oncology Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Precision Oncology Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Precision Oncology Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Precision Oncology Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Precision Oncology Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Precision Oncology Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Precision Oncology Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Precision Oncology Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Precision Oncology Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Precision Oncology Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Precision Oncology Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Precision Oncology Industry Drivers and Opportunities
7. PRECISION ONCOLOGY MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. PRECISION ONCOLOGY COMPANY PROFILES
8.1 Profiles of Leading Precision Oncology Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
Acrivon Therapeutics
Bioserve
Exact Sciences Corp
Illumina Inc
Invitae Corp
Laboratory Corp Of America Holding
Qiagen N.V.
Rain Oncology Inc
Relay Therapeutics
Strata Oncology Inc
Thermo Fisher Scientific Inc
Variantyx Inc
Xilis Inc
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
